These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11197168)

  • 1. Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.
    Griese M; von Bredow C; Birrer P
    Electrophoresis; 2001 Jan; 22(1):165-71. PubMed ID: 11197168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity.
    Griese M; von Bredow C; Birrer P; Schams A
    Pulm Pharmacol Ther; 2001; 14(6):461-7. PubMed ID: 11782126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
    von Bredow C; Birrer P; Griese M
    Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
    Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
    J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G; Hoffjan S; Mosler K; Schuster A
    Lung; 2001; 179(3):185-94. PubMed ID: 11891608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
    Ratjen F; Paul K; van Koningsbruggen S; Breitenstein S; Rietschel E; Nikolaizik W
    Pediatr Pulmonol; 2005 Jan; 39(1):1-4. PubMed ID: 15532079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
    McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
    Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.
    Tsao FH; Meyer KC; Chen X; Rosenthal NS; Hu J
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):120-8. PubMed ID: 9448053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
    Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
    Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of human bronchoalveolar lavage fluid: expression profiling of surfactant-associated protein A isomers derived from human pulmonary alveolar proteinosis using immunoaffinity detection.
    He C
    Proteomics; 2003 Jan; 3(1):87-94. PubMed ID: 12548638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.
    Virella-Lowell I; Poirier A; Chesnut KA; Brantly M; Flotte TR
    Gene Ther; 2000 Oct; 7(20):1783-9. PubMed ID: 11083501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
    Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
    Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein deficiency in familial interstitial lung disease.
    Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
    J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the lung proteome in cystic fibrosis.
    Gharib SA; Vaisar T; Aitken ML; Park DR; Heinecke JW; Fu X
    J Proteome Res; 2009 Jun; 8(6):3020-8. PubMed ID: 19354268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
    Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
    Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.